532 related articles for article (PubMed ID: 19421967)
1. Balancing risk and benefit with oral hypoglycemic drugs.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
[TBL] [Abstract][Full Text] [Related]
2. Metformin: a safe and effective treatment in the management of NIDDM.
Kilo C
Mo Med; 1997 Mar; 94(3):114-23. PubMed ID: 9071866
[TBL] [Abstract][Full Text] [Related]
3. Metformin-associated lactic acidosis: case reports and literature review.
Chang CT; Chen YC; Fang JT; Huang CC
J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
[TBL] [Abstract][Full Text] [Related]
4. Metformin-associated lactic acidosis in a low risk patient.
Ellis AK; Iliescu EA
Can J Clin Pharmacol; 2001; 8(2):104-6. PubMed ID: 11493939
[TBL] [Abstract][Full Text] [Related]
5. Selecting among ADA/EASD tier 1 and tier 2 treatment options.
McGill JB
J Fam Pract; 2009 Sep; 58(9 Suppl Treating):S26-34. PubMed ID: 19744422
[TBL] [Abstract][Full Text] [Related]
6. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
Goo AK; Carson DS; Bjelajac A
J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
[TBL] [Abstract][Full Text] [Related]
7. Metformin induced lactic acidosis--particularities and course.
Strugaru AM; Botnariu G; Agoroaei L; Grigoriu IC; Butnaru E
Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):1035-42. PubMed ID: 24502087
[TBL] [Abstract][Full Text] [Related]
8. [Lactic acidosis feared adverse effect of metformin treatment. New guidelines can increase vigilance].
Berne C; Hietala SO
Lakartidningen; 1999 Dec; 96(50):5598-9. PubMed ID: 10643216
[No Abstract] [Full Text] [Related]
9. Metformin in noninsulin-dependent diabetes mellitus.
Lee AJ
Pharmacotherapy; 1996; 16(3):327-51. PubMed ID: 8726592
[TBL] [Abstract][Full Text] [Related]
10. Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.
Altun E; Kaya B; Paydaş S; Sarıakçalı B; Karayaylalı I
Hemodial Int; 2014 Apr; 18(2):529-31. PubMed ID: 24299454
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose.
Yang PW; Lin KH; Lo SH; Wang LM; Lin HD
Kaohsiung J Med Sci; 2009 Feb; 25(2):93-7. PubMed ID: 19321413
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.
Nesto RW; Bell D; Bonow RO; Fonseca V; Grundy SM; Horton ES; Le Winter M; Porte D; Semenkovich CF; Smith S; Young LH; Kahn R; ;
Circulation; 2003 Dec; 108(23):2941-8. PubMed ID: 14662691
[No Abstract] [Full Text] [Related]
13. [Metformin-associated lactic acidosis with acute renal failure in type 2 diabetes mellitus]].
Rahn A
Med Klin (Munich); 2002 Jul; 97(7):435; author reply 436. PubMed ID: 12168485
[No Abstract] [Full Text] [Related]
14. [Lactic acidosis and metformin implicated: why better information about risk factors?].
Machet G; Coudray JM
Therapie; 2000; 55(2):283-94. PubMed ID: 10967701
[TBL] [Abstract][Full Text] [Related]
15. Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes.
Loebstein R; Dushinat M; Vesterman-Landes J; Silverman B; Friedman N; Katzir I; Kurnik D; Lomnicky Y; Kokia E; Halkin H
J Clin Pharmacol; 2011 Feb; 51(2):173-80. PubMed ID: 20484611
[TBL] [Abstract][Full Text] [Related]
16. Metformin: safety in cardiac patients.
Khurana R; Malik IS
Postgrad Med J; 2010 Jun; 86(1016):371-3. PubMed ID: 20547605
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone does not alter the pharmacokinetics of metformin.
Di Cicco RA; Allen A; Carr A; Fowles S; Jorkasky DK; Freed MI
J Clin Pharmacol; 2000 Nov; 40(11):1280-5. PubMed ID: 11075314
[TBL] [Abstract][Full Text] [Related]
18. The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
Acta Diabetol; 2009 Jun; 46(2):145-54. PubMed ID: 19194648
[TBL] [Abstract][Full Text] [Related]
19. [Metformin and contrast media--increased risk of lactic acidosis?].
Kløw NE; Draganov B; Os I
Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1829. PubMed ID: 11464691
[TBL] [Abstract][Full Text] [Related]
20. Biguanide related lactic acidosis: incidence and risk factors.
Aguilar C; Reza A; García JE; Rull JA
Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
